GALUPPINI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 5.740
AS - Asia 2.868
EU - Europa 1.879
AF - Africa 714
SA - Sud America 709
OC - Oceania 63
Continente sconosciuto - Info sul continente non disponibili 36
Totale 12.009
Nazione #
US - Stati Uniti d'America 5.362
SG - Singapore 1.013
CN - Cina 618
BR - Brasile 467
IT - Italia 393
HK - Hong Kong 318
VN - Vietnam 201
DE - Germania 192
SE - Svezia 136
PL - Polonia 107
FI - Finlandia 101
GB - Regno Unito 91
NL - Olanda 83
RU - Federazione Russa 83
BJ - Benin 75
FR - Francia 70
KR - Corea 54
EC - Ecuador 47
AT - Austria 46
CA - Canada 41
AR - Argentina 37
IN - India 37
MX - Messico 37
JP - Giappone 34
TR - Turchia 32
IE - Irlanda 31
CI - Costa d'Avorio 30
ID - Indonesia 30
CH - Svizzera 29
EG - Egitto 29
AL - Albania 27
PE - Perù 27
VE - Venezuela 27
MK - Macedonia 26
UA - Ucraina 26
CR - Costa Rica 25
DK - Danimarca 25
DO - Repubblica Dominicana 25
UZ - Uzbekistan 25
BY - Bielorussia 24
BZ - Belize 24
CO - Colombia 24
CZ - Repubblica Ceca 24
IQ - Iraq 24
PS - Palestinian Territory 24
BE - Belgio 23
GT - Guatemala 23
ME - Montenegro 23
AE - Emirati Arabi Uniti 22
GM - Gambi 22
GR - Grecia 22
KH - Cambogia 22
MA - Marocco 22
EE - Estonia 21
ES - Italia 21
LV - Lettonia 21
MD - Moldavia 21
TN - Tunisia 21
AM - Armenia 20
AZ - Azerbaigian 20
GE - Georgia 20
GN - Guinea 20
KE - Kenya 20
KZ - Kazakistan 20
MY - Malesia 20
PH - Filippine 20
PY - Paraguay 20
ZA - Sudafrica 20
BD - Bangladesh 19
HR - Croazia 19
LA - Repubblica Popolare Democratica del Laos 19
LC - Santa Lucia 19
MN - Mongolia 19
MW - Malawi 19
PA - Panama 19
PK - Pakistan 19
RS - Serbia 19
SN - Senegal 19
ZW - Zimbabwe 19
BB - Barbados 18
BO - Bolivia 18
CD - Congo 18
CY - Cipro 18
IR - Iran 18
NE - Niger 18
NO - Norvegia 18
SK - Slovacchia (Repubblica Slovacca) 18
SO - Somalia 18
TH - Thailandia 18
HN - Honduras 17
IS - Islanda 17
JM - Giamaica 17
JO - Giordania 17
KG - Kirghizistan 17
NP - Nepal 17
NZ - Nuova Zelanda 17
RO - Romania 17
UY - Uruguay 17
XK - ???statistics.table.value.countryCode.XK??? 17
CW - ???statistics.table.value.countryCode.CW??? 16
Totale 11.260
Città #
Fairfield 781
Ashburn 711
Singapore 591
Chandler 410
Woodbridge 349
Cambridge 327
Houston 307
Hong Kong 301
Ann Arbor 277
Seattle 271
Wilmington 238
Beijing 197
Padova 143
Santa Clara 116
Boardman 112
San Diego 100
Los Angeles 94
Hefei 78
Cotonou 70
Bytom 64
Medford 63
Princeton 63
Munich 59
Ho Chi Minh City 55
Seoul 51
New York 50
São Paulo 49
Des Moines 47
Helsinki 46
Nuremberg 37
Hanoi 34
Chicago 33
Dong Ket 33
Abidjan 30
Buffalo 27
Warsaw 26
London 25
Dublin 24
Milan 24
Tokyo 24
Turku 24
Vienna 24
San José 22
Tashkent 22
Nanjing 21
Podgorica 21
Phnom Penh 20
Dakar 19
Panama City 19
Ulan Bator 19
Baku 18
Harare 18
Lima 18
Minsk 18
Riga 18
Roxbury 18
Vientiane 18
Amman 17
Bridgetown 17
Brooklyn 17
Castries 17
Mexico City 17
Montreal 17
Conakry 16
Dallas 16
Guayaquil 16
Kampala 16
Niamey 16
Redondo Beach 16
Salt Lake City 16
Stockholm 16
Tirana 16
Bishkek 15
Kigali 15
Montevideo 15
Rio de Janeiro 15
Tallinn 15
Yerevan 15
Brasília 14
Chisinau 14
Denver 14
Kinshasa 14
Kuala Lumpur 14
Quito 14
Willemstad 14
Andorra la Vella 13
Antananarivo 13
Brussels 13
Guatemala City 13
Libreville 13
Lilongwe 13
Nouakchott 13
Reykjavik 13
Secaucus 13
Skopje 13
Belize City 12
Buenos Aires 12
Curitiba 12
Djibouti 12
Dushanbe 12
Totale 7.298
Nome #
F-actin dynamics regulates mammalian organ growth and cell fate maintenance 330
PROGNOSTIC SIGNIFICANCE OF TERT PROMOTER AND BRAF MUTATIONS IN TIR-4 AND TIR-5 THYROID CYTOLOGY 306
The Hobnail variant of Papillary Thyroid Carcinoma: clinical/molecular characteristics of a large monocentric series and comparison with conventional histotypes 270
A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC 267
Overexpression of L-Type amino acid transporter 1 (LAT1) and 2 (LAT2): Novel markers of neuroendocrine tumors 231
Novel Prognostic Factors Associated with Cell Cycle Control in Sporadic Medullary Thyroid Cancer Patients 225
BRAF analysis before surgery for papillary thyroid carcinoma: correlation with clinicopathological features and prognosis in a single-institution prospective experience 217
BRAF p.V600E-specific immunohistochemical assessment in colorectal cancer endoscopy biopsies is consistent with the mutational profiling 216
Programmed cell death-ligand 1 (PD-L1) overexpression in ampulla of Vater carcinoma and its pre-invasive lesions 213
Papillary thyroid carcinoma (PTC) in Lynch syndrome: Report of two cases and discussion on Lynch syndrome behaviour and genetics 208
Catechol-O-Methyltransferase Genetic Reduction Evokes Small-Bowel Neuromuscular Adaptive Changes 200
The PDCD4/miR-21 pathway in medullary thyroid carcinoma. 199
Adenosquamous gallbladder carcinoma: Multigene hotspot mutational profiling reveals a monoclonal origin of the two components 197
Concomitant IDH-wildtype glioblastoma and IDH1-mutant anaplastic astrocytoma in a patient with constitutional mismatch repair deficiency syndrome 193
Aberrant expression of CD10 and BCL6 in mantle cell lymphoma 189
Antibiotic-induced dysbiosis of the microbiota impairs gut neuromuscular function in juvenile mice 188
Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer 179
Frequency and significance of Ras, Tert promoter, and Braf mutations in cytologically indeterminate thyroid nodules: A monocentric case series at a tertiary-level Endocrinology unit 173
The rising incidence of papillary thyroid cancer: More cancers or more assessments? 172
Periodontal Injection of Lipopolysaccharide Promotes Arthritis Development in Mice 170
Differentiated Thyroid Carcinoma in Pediatric Age: Genetic and Clinical Scenario 169
Gut Microbiota Depletion Affects Enteric Nervous System Homeostasis in Juvenile Mice 168
microRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome. 166
Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma 165
MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions 161
Tumor budding is an adverse prognostic marker in intestinal-type sinonasal adenocarcinoma and seems to be unrelated to epithelial-mesenchymal transition 161
Polydatin prevents calcium pyrophosphate crystal-induced arthritis in mice 161
The molecular landscape of primary acral melanoma: A multicenter study of the italian melanoma intergroup (imi) 160
MiR-375 and YAP1 expression profiling in medullary thyroid carcinoma and their correlation with clinical–pathological features and outcome 158
MicroRNAs as Predictive Biomarkers of Resistance to Targeted Therapies in Gastrointestinal Tumors 156
Medullary Thyroid Carcinoma in a Patient with MEN 1 Syndrome. Case Report and Literature Review 151
Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling 146
First Evidence of Mineralocorticoid Receptor Gene and Protein Expression in Rat and Human Thyroid Tissues and Cell Cultures 145
Double CYP11B1/CYP11B2 Immunohistochemistry and Detection of KCNJ5 Mutations in Primary Aldosteronism 145
Unique Case of a Large Indolent Medullary Thyroid Carcinoma: Time to Reconsider the Medullary Thyroid Adenoma Entity? 145
Molecular profiling of appendiceal serrated lesions, polyps and mucinous neoplasms: a single-centre experience 145
Gastric metastases of breast cancer: Histopathological and molecular characterization of a single Institution case series 144
Gut dysmotility after catechol-O-methyltransferase and dopamine transporter genetic reduction in mice: implication in irritable bowel syndrome pathogenesis. 142
Serum miR-375 for Diagnostic and Prognostic Purposes in Medullary Thyroid Carcinoma 142
Epstein-Barr virus associated gastric dysplasia: a new rare entity? 142
PDCD4 expression in thyroid neoplasia 139
Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and Shadows 139
Bactericidal/Permeability-Increasing Protein Downregulates the Inflammatory Response in In Vivo Models of Arthritis 138
First proof of association between autoimmune polyglandular syndrome and multiple endocrine neoplasia in humans 136
The role of the size in thyroid cancer risk stratification 136
Tumor mutation burden: From comprehensive mutational screening to the clinic 134
Mirnas involved in esophageal carcinogenesis and miRNA- related therapeutic perspectives in esophageal carcinoma 131
Gastritis: update on etiological features and histological practical approach 130
Programmed cell death 4 (PDCD4) as a novel prognostic marker for papillary thyroid carcinoma 127
Diagnostic accuracy of antiendomysial antibodies biopsy test for celiac disease in clinical practice 126
Can ultrasensitive thyroglobulin immunoassays avoid the need for ultrasound in thyroid cancer follow-up? 126
Predictors of neoplastic progression in gastroesophageal lesions indefinite for dysplasia 125
Toll-Like Receptor 4 Modulates Small Intestine Neuromuscular Function through Nitrergic and Purinergic Pathways 122
The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team Evaluation 121
Gut microbiota depletion alters the structure and function of the enteric nervous system in adolescent mice. 119
Effect of intra-articular injection of a hyaluronic acid-alendronate conjugate on post-traumatic osteoarthritis induced by destabilization of the medial meniscus in rats 116
Molecular landscapes of gastric pre-neoplastic and pre-invasive lesions 115
The Role of the Pathologist in the Next-Generation Era of Tumor Molecular Characterization 112
Molecular subtyping of gastroesophageal dysplasia heterogeneity according to TCGA/ACRG classes 112
Calcitonin levels in autoimmune atrophic gastritis-related hypergastrinemia 111
Long-Term Outcomes after Surgery for Pheochromocytoma and Sympathetic Paraganglioma 110
A KRAS-responsive long non-coding RNA controls microRNA processing 109
LPS-INDUCED PERIODONTITIS PROMOTES ARTHRITIS DEVELOPMENT IN MICE 108
Tumour budding seems to be independent to epithelial-mesenchymal transition in intestinal-type sinonasal adenocarcinoma 107
The impact of recent next generation sequencing and the need for a new classification in gastric cancer 106
The Histopathological Landscape of Precursor Lesions of Gastro-entero-pancreatic Neuroendocrine Neoplasms 103
Tumor Grade and Molecular Characteristics Associated with Survival in Sporadic Medullary Thyroid Carcinoma 103
Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer. 103
MicroRNAs in Medullary Thyroid Carcinoma: A State of the Art Review of the Regulatory Mechanisms and Future Perspectives 103
Tumor budding is an adverse prognostic marker in intestinal-type sinonasal adenocarcinoma and seems to be unrelated to epithelial-mesenchymal transition 102
Synchronous medullary, papillary and follicular carcinomas in the same thyroid: case report and review of literature. 100
The histomorphological and molecular landscape of colorectal adenomas and serrated lesions 98
Prognostic significance of the sum of the diameters of single foci in multifocal papillary thyroid cancer: the concept of new-old tumor burden 96
TRK Protein Expression in Merkel Cell Carcinoma Is Not Caused by NTRK Fusions 90
Current role of non-coding RNAs in the clinical setting 89
Prophylactic and Early Thyroidectomy in RET Germline Mutation Carriers in Pediatric and Adult Population: Long-Term Outcomes of a Series of 63 Patients 85
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study 85
The evolving landscape of anatomic pathology 85
Liver Metastases of Unknown Primary Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors: A Case Report and Literature Review 81
Uncommon adrenal rest tumors and massive adrenal enlargement in adult with congenital adrenal hyperplasia mimicking metastasis from pleomorphic sarcoma 80
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 80
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study) 75
Medico-Legal issues in a neurosurgical case series of Rathke Cleft Cysts. Informed consent, complications and medical liability 59
Refining the ITBCC tumor budding scoring system with a "zero-budding" category in colorectal cancer 58
Mastering esophageal cancer imaging: what radiologists need to know 22
Totale 12.167
Categoria #
all - tutte 40.649
article - articoli 40.313
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.962


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021870 0 0 0 0 24 64 23 74 111 232 158 184
2021/20221.064 35 78 109 81 90 89 90 78 83 38 79 214
2022/2023744 147 98 19 110 96 97 5 37 72 15 41 7
2023/2024527 14 61 55 48 58 59 58 25 32 12 58 47
2024/20252.292 19 121 118 65 223 84 106 224 216 98 391 627
2025/20264.749 627 934 1.178 1.570 440 0 0 0 0 0 0 0
Totale 12.167